Clinical Trial Update: A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tovorafenib in pediatric and young adult participants with relapsed or progressive low-grade glioma and advanced solid tumor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma
• Solid Tumor

Drugs mentioned

• tovorafenib (tovorafenib)

Snippet

Sponsor: Day One Biopharmaceuticals, Inc. | Conditions: Low-grade Glioma, Advanced Solid Tumor | Phase 2 | Status: RECRUITING